Subscribe to Our Newsletter

Success! Now Check Your Email

To complete Subscribe, click the confirmation link in your inbox. If it doesn’t arrive within 3 minutes, check your spam folder.

Ok, Thanks

Science

A collection of 75 Posts

23andMe to face legal showdown over DNA data sale post image

23andMe to face legal showdown over DNA data sale

Eli Lilly shares boosted by Mounjaro and Zepbound diabetes test results post image

Eli Lilly shares boosted by Mounjaro and Zepbound diabetes test results

AstraZeneca’s UK vaccine hub under threat amid government funding rug-pull post image

AstraZeneca’s UK vaccine hub under threat amid government funding rug-pull

Rocket Lab propelled higher by expectation beating financials post image

Rocket Lab propelled higher by expectation beating financials

Eli Lilly shares boosted as financials beat forecasts thanks to Mounjaro and Zepbound post image

Eli Lilly shares boosted as financials beat forecasts thanks to Mounjaro and Zepbound

Novo Nordisk hit as revenue and profit growth failed to meet high expectations post image

Novo Nordisk hit as revenue and profit growth failed to meet high expectations

GSK investors vexed as vax sales dented otherwise strong quarter post image

GSK investors vexed as vax sales dented otherwise strong quarter

Novo Nordisk and Eli Lilly fell as Roche made weight loss breakthrough post image

Novo Nordisk and Eli Lilly fell as Roche made weight loss breakthrough

Pfizer shares boosted as it advances development of GLP weight loss pill post image

Pfizer shares boosted as it advances development of GLP weight loss pill

BP warns energy transition is at risk of being ‘disorderly’ and more costly, says global demand is still rising post image

BP warns energy transition is at risk of being ‘disorderly’ and more costly, says global demand is still rising

Novo Nordisk shares slipped after researchers boosted Eli Lilly’s weight loss drugs post image

Novo Nordisk shares slipped after researchers boosted Eli Lilly’s weight loss drugs

SpaceX was valued at $210bn as it lands $843mln ISS contract post image

SpaceX was valued at $210bn as it lands $843mln ISS contract